Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021

EMCDDA (2021)

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021

English English
PDF Document PDF Document

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new trends and developments which may have implications for policy and practice. The report explores the situation in the EU Member States from June 2020 to February 2021, particularly changes in drug markets, patterns of use, harms and drug services, both in the community and in prisons.

Open "Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021"
More details
The selected activity requires you to open a PDF document from an external website.
Click the button below to open the requested document in a new browser tab or window.
To return to this page, switch back to this browser tab, or close the newly opened page.
Open "Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study April 2021"
In partnership with:
ISFF
FUAS
Correlation Network